TITLE

Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002–2009

AUTHOR(S)
Rotman, Stephen R.; Bishop, Tara F.
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and Aims: Anecdotal reports and studies of select populations suggest that the use of proton pump inhibitors (PPIs) has increased since their introduction. We sought to determine recent trends in PPI use in the U.S. outpatient setting and characteristics of patients and physicians that may predict their use. Methods: We used data from the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS) to estimate the prevalence of visits in which patients used PPIs from 2002 to 2009. We tested for associations between PPI use and patient, physician, and practice characteristics using data from 2009. We also estimated the prevalence of visits in which PPIs were used by patients without gastrointestinal complaints, diagnoses, or other indications for their use and tested for associations between patient and physician characteristics and PPI use in patients with no documented indication. Results: PPIs were used in 4.0% of visits in 2002 and 9.2% in 2009 (p<0.001 for trend across years). The use of omeprazole (0.9% in 2002 to 3.9% in 2009, p<0.001), esomeprazole (0.9% in 2002 to 2.3% in 2009, p<0.001), and pantoprazole (0.6% in 2002 to 1.6% in 2009, p<0.001) increased significantly over the study period. Among visits by patients using PPIs, 62.9% documented no gastrointestinal complaints, gastrointestinal diagnoses, or other indicated reason for their use. Conclusions: We found that PPI use increased significantly from 2002 to 2009 as did documented indications for their use. Newly-prescribed PPI use did not change from 2006 to 2009. More research is needed to determine whether PPIs are overused in the U.S. outpatient setting.
ACCESSION #
87624249

 

Related Articles

  • Fundic Gland Polyps and Association with Proton Pump Inhibitor Intake: A Prospective Study in 1,780 Endoscopies. Zelter, Adriana; Fernández, José; Bilder, Claudio; Rodríguez, Pablo; Wonaga, Andrés; Dorado, Fernanda; Galich, Miriam; Viola, Luis // Digestive Diseases & Sciences;Jun2011, Vol. 56 Issue 6, p1743 

    Background and Aims: Fundic gland polyps (FGPs) are incidentally found when an endoscopy is performed for a non-related indication. Some authors suggested a relationship with proton pump inhibitor (PPI) intake. We aimed to determine their prevalence and association with PPI intake. Methods: We...

  • The Pharmacovigilance of Pantoprazole: The Results of Postmarketing Surveillance on 11 541 Patients in England. Wilton, L.V.; Key, C.; Shakir, S.A.W. // Drug Safety;Jan2003, Vol. 26 Issue 2, p121 

    Objective: To conduct a postmarketing surveillance study involving patients treated with pantoprazole in general practice in the 6-month period following the launch of this drug in November 1996. Prescription-event monitoring (PEM) provides data on a large cohort of patients in ‘real...

  • The Myth and Truth about the Usefulness of Second-Look Endoscopy Following Endoscopic Submucosal Resection. Hye Kang Kim; Dae Young Cheung // Gut & Liver;Sep2014, Vol. 8 Issue 5, p459 

    An introduction is presented in which the editor discusses various reports within the issue on topics including endoscopic submucosal dissection for gastric neoplasms, in-hospital setting for an out-patients setting and proton pump inhibitor for peptic ulcer disease.

  • Stopping proton pump inhibitor use may cause heartburn.  // Mayo Clinic Health Letter;Jan2010, Vol. 28 Issue 1, p4 

    The article discusses a study published in the July 2009 issue of "Gastroenterology," which showed that stopping the use of an acid-suppressing proton pump inhibitor (PPI) may temporarily increase stomach acid secretion, leading to heartburn withdrawal symptoms. These PPIs include esomeprazole,...

  • Supragastric Belching in Patients With Reflux Symptoms. Hemmink, Gerrit J M; Bredenoord, Albert J; Weusten, Bas L A M; Timmer, Robin; Smout, André J P M // American Journal of Gastroenterology;Aug2009, Vol. 104 Issue 8, p1992 

    OBJECTIVES:Supragastric belching is a distinct belch pattern found in patients with excessive belching (aerophagia). Patients with gastroesophageal reflux disease (GERD) may also complain of belching. It has been shown that GERD patients swallow air more frequently and have more air-containing...

  • Fecal Incontinence: Prevalence, Severity, and Quality of Life Data from an Outpatient Gastroenterology Practice. Alsheik, Eva H.; Coyne, Thomas; Hawes, Sara K.; Merikhi, Laleh; Naples, Scott P.; Kanagarajan, Nandhakumar; Reynolds, James C.; Myers, Scott E.; Ahmad, Asyia S. // Gastroenterology Research & Practice;2012, p1 

    Background. The prevalence of fecal incontinence varies tremendously as a result of inadequate data collection methods. Few office-based studies have assessed the prevalence of fecal incontinence and none have looked at modifiable risk factors or effect on quality of life. Design, Settings,...

  • Chronic Proton Pump Inhibitor Therapy Associated with Increased Development of Fundic Gland Polyps. Ally, Mazer R.; Veerappan, Ganesh R.; Maydonovitch, Corinne L.; Duncan, Timothy J.; Perry, Joseph L.; Osgard, Eric M.; Wong, Roy K. H. // Digestive Diseases & Sciences;Dec2009, Vol. 54 Issue 12, p2617 

    Fundic gland polyps (FGP) have been implicated with long-term proton pump inhibitor (PPI) use. We attempted to investigate the impact of length and dosage of PPI therapy on the development of FGP. A retrospective cohort study of all patients who had gastric polyps removed during elective upper...

  • Prescribing Proton Pump Inhibitors: Is it Time To Pause and Rethink? Vakil, Nimish // Drugs;2012, Vol. 72 Issue 4, p437 

    Proton pump inhibitors (PPIs) are among the most widely used agents in the world. The prevalence of reflux disease is increasing, as is the incidence of oe-sophageal adenocarcinoma, a complication that is strongly correlated with chronic reflux disease. Although these agents are generally safe,...

  • Proton Pump Inhibitors.  // Current Medical Literature: Gastroenterology;2008, Vol. 27 Issue 4, p120 

    The article presents abstracts of research on proton pump inhibitors (PPI) including the "Addition of H2 Receptor Antagonist to PPI in Improving Acid Control and Decreases Nocturnal Acid Breakthrough," and "Predictable Prolonged Suppression of Gastric Acidity With a Novel Proton Pump Inhibitor,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics